Noyes Jane, Morgan Karen, Walton Phillip, Roberts Abigail, Mclaughlin Leah, Stephens Michael
School of Social Sciences, Bangor University, Wales, UK.
Major Health Conditions Policy Team, Directorate of Health Policy, Health and Social Services Group, Welsh Government, Cardiff, UK.
BMJ Open. 2017 Oct 12;7(10):e017287. doi: 10.1136/bmjopen-2017-017287.
The Human Transplantation (Wales) Act 2013 (the Act) introduced a 'soft opt-out' system of organ donation on 1 December 2015. Citizens are encouraged to make their organ donation decision known during their lifetime. In order to work, the Act and media campaign need to create a context, whereby organ donation becomes the norm, and create a mechanism for people to behave as intended (formally register their decision; consider appointing a representative; convey their donation decision to their families and friends or do nothing-deemed consent). In addition, family members/appointed representatives need to be able to put their own views aside to support the decision of their loved one. The aim of this study is to evaluate initial implementation, outcomes and impact on families and appointed representatives who were approached about organ donation during the first 18 months.
Prospective mixed-method coproductive study undertaken with National Health Service Blood and Transplant (NHSBT), and multiple patient/public representatives. The study is designed to collect information on all cases who meet specified criteria (≥18 years, deceased person voluntarily resident in Wales and died in Wales or England) whose family were approached between 1 December 2015 and 31 June 2017). Data for analysis include: NHSBT routinely collected anonymised audit data on all cases; Specialist Nurse in Organ Donation (SNOD) completed anonymised form for all cases documenting their perception of the families' understanding of the Act, media campaign and outcome of the donation approach; questionnaires and depth interviews with any family member or appointed representative (minimum 50 cases). Additional focus groups and interviews with SNODs. Anonymised donation outcomes and registration activity reports for Wales provide additional context.
Approved by NHSBT Research, Innovation and Technology Advisory Group on 23 October 2015; Wales Research Ethics Committee 5 (IRAS190066; Rec Reference 15/WA/0414) on 25 November 2015 and NHSBT R&D Committee (NHSBT ID: AP-15-02) on 24 November 2015.
The protocol is registered on the Health and Care Research Wales Clinical Research Portfolio. Study ID number 34396, www.ukctg.nihr.ac.uk.
《2013年人体移植(威尔士)法案》(以下简称“该法案”)于2015年12月1日引入了“软性退出”器官捐赠系统。鼓励公民在生前表明其器官捐赠决定。为使该法案及媒体宣传活动发挥作用,需要营造一种环境,使器官捐赠成为常态,并建立一种机制,让人们按照预期行事(正式登记其决定;考虑指定一名代表;将其捐赠决定告知家人和朋友或不采取任何行动——视为同意)。此外,家庭成员/指定代表需要能够抛开自己的观点,支持其亲人的决定。本研究的目的是评估在最初18个月内对被询问器官捐赠事宜的家庭和指定代表的初步实施情况、结果及影响。
与英国国民医疗服务体系血液与移植部门(NHSBT)以及多名患者/公众代表开展前瞻性混合方法协同生产研究。该研究旨在收集所有符合特定标准(年龄≥18岁、生前自愿居住在威尔士且在威尔士或英格兰去世)且其家人在2015年12月1日至2017年6月31日期间被询问的案例信息。用于分析的数据包括:NHSBT对所有案例常规收集的匿名审计数据;器官捐赠专科护士(SNOD)为所有案例填写的匿名表格,记录他们对家属对该法案、媒体宣传活动及捐赠询问结果的理解情况;对任何家庭成员或指定代表进行问卷调查和深度访谈(至少50个案例)。另外还有与SNODs的焦点小组讨论和访谈。威尔士匿名捐赠结果及登记活动报告提供了更多背景信息。
2015年10月23日获得NHSBT研究、创新与技术咨询小组批准;2015年11月25日获得威尔士研究伦理委员会5(IRAS190066;参考编号15/WA/0414)批准,2015年11月24日获得NHSBT研发委员会(NHSBT ID:AP - 15 - 02)批准。
该方案已在威尔士卫生与护理研究临床研究项目中注册。研究编号34396,网址为www.ukctg.nihr.ac.uk。